Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves muscle mass in patients.The ...
Monthly Prescribing Reference1mon
AUDACITY Trial: Weight Loss Observed With Allurion Intragastric Balloon
Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable ... for people with obesity,” said Dr Shelby Sullivan, Professor of Medicine and ...
Seeking Alpha19d
Allurion stock soars 70% on weight-loss therapy update
Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular session 21% higher on news the company plans to conduct a clinical study of its gastric balloon ...
Nasdaq19d
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...
Investing21d
Allurion secures new patent for gastric balloon technology
Allurion's flagship offering, the Allurion Program, integrates the Allurion Gastric Balloon, a swallowable device that aids in weight loss without the need for a surgical procedure. The program also ...